- Last month, the National Academies of Science, Engineering, and Medicine (NASEM) released a 401-page report which analyzed the 2022 infant formula shortage, highlighted the vulnerabilities in the infant formula market,
INFANT FORMULA
Senators Propose Heavy Metal Legislation with Product Testing Requirements
Posted on
- Earlier this month, Senators Amy Klobuchar and Tammy Duckworth announced the introduction of legislation (the “Baby Food Safety Act of 2024”) intended to increase the safety of certain foods, including
FTC Releases Report on Infant Formula Market
Posted on
- Earlier this month, the Federal Trade Commission (FTC) released a report which analyzes market factors contributing to the infant formula market disruptions that occurred in 2022 following the recall of
FDA Releases Infant Formula Risk Management Plan Fact Sheet
Posted on
- On November 22, 2023, FDA released a one-page fact sheet answering questions regarding the redundancy risk management plan requirement in the Food and Drug Omnibus Reform Act of 2022. The
FDA Deputy Commissioner for Human Foods Expresses Commitment to Human Foods Program Framework
Posted on
- James Jones, the newly appointed Deputy Commissioner for Human Foods, released a statement on October 19 outlining his commitment to Commissioner Robert Califf’s framework for the proposed Human Foods Program
FDA Updates Compliance Program for Infant Formula
Posted on
- FDA updated its infant formula compliance program for FDA investigators, laboratory analysts, and compliance officers. The program comprehensively outlines the agency’s approach towards inspections, sample collection, sample analysis, and compliance
FDA Provides Update on the Cronobacter Prevention Strategy in Powdered Infant Formula
Posted on
- Continuous collaboration with industry,
FDA Issues Warning Letters to Three Infant Formula Manufacturers
Posted on
- On August 30, 2023, the U.S. Food and Drug Administration (FDA) issued warning letters to three infant formula manufacturers as part of the Agency’s recent push to enhance regulatory oversight
Bipartisan Lawmakers Seek to Remove Tariffs on Infant Formula with Proposed Formula 3.0 Act
Posted on
- On June 1, a group of bipartisan lawmakers led by Senator Mike Lee, R-UT, introduced the Formula 3.0 Act which would permanently remove tariffs and other trade restrictions on imported
FDA Publishes Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market
Posted on
- On March 28, FDA released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. The strategy follows a months-long infant formula shortage sparked by